HR
BMY icon

Hayden Royal’s Bristol-Myers Squibb BMY Stock Holding History

Hayden Royal’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$173K Buy
+2,768
New +$162K 0.41% 91
2019
Q1 		– Sell
-4,378
Closed -$228K – 132
2018
Q4 		$228K Buy
+4,378
New +$235K 0.12% 170

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hayden Royal's BMY Position: Q4 2021 in Review

Hayden Royal opened a new position in Bristol-Myers Squibb (BMY) in Q4 2021: 2,768 shares worth $173K. The stake represents 0.41% of the portfolio and ranks #91 among its holdings. This is a return to the name: Hayden Royal previously reported a position in BMY as recently as Q4 2018.

Hayden Royal first reported a position in BMY in Q4 2018 and has held it in 2 quarters since. The position peaked at $228K in Q4 2018. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Hayden Royal held 2,768 shares of Bristol-Myers Squibb worth $173K as of Q4 2021.
  • Bristol-Myers Squibb was a new Hayden Royal position in Q4 2021.
  • Bristol-Myers Squibb made up 0.41% of Hayden Royal's portfolio in Q4 2021, its #91 holding.
  • Hayden Royal first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 2 quarters since.
  • Hayden Royal's Bristol-Myers Squibb position peaked at $228K in Q4 2018.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Hayden Royal's 13F filing for Q4 2021, filed 7 Feb 2022.